Close Menu

NEW YORK (GenomeWeb) — The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded a contract worth up to $150 million to DxTerity Diagnostics to develop and deliver its REDI-Dx biodosimetry test for radiation exposure, the firm announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.